Literature DB >> 21797012

Simultaneous determination of benzimidazoles and their metabolites in plasma using high-performance liquid chromatography/tandem mass spectrometry: application to pharmacokinetic studies in rabbits.

Xinle Zhu1, Shuhuai Wang, Qi Liu, Qian Xu, Congmin Zhang, Shixin Xu, Xia Wang, Dan Li, Haiyan Hu.   

Abstract

An HPLC/MS/MS method was developed for the simultaneous determination of the following benzimidazole anthelmintics and metabolites in plasma: flubendazole, albendazole, fenbendazole, mebendazole, thiabendazole, hydrolyzed flubendazole, albendazole sulfoxide, albendazole sulfone, albendazole aminosulfone, oxfendazole, fenbendazole sulfone, aminomebendazole, hydroxymebendazole, and 5-hydroxythiabendazole. The sample preparation process involved a pH-dependent extraction of the analytes. Chromatographic separation was performed on a C18 column with a mobile phase gradient starting with methanol-water (20 + 80, v/v) containing 0.1% formic acid. The overall average recoveries of the analytes based on a matrix-matched calibration ranged from 75.0 to 120.0%, with RSD values of <20.0%. The LODs ranged from 0.08 to 2.0 microg/kg and the LOQs from 0.3 to 5.0 microg/kg. The validated method was used in pharmacokinetic studies of benzimidazole compounds in rabbits, and the elimination of the metabolites was measured quantitatively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21797012

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  3 in total

1.  Liquid chromatography--tandem mass spectrometry method for simultaneous determination of albendazole and albendazole sulfoxide in human plasma for bioequivalence studies.

Authors:  Dhiraj M Rathod; Keyur R Patel; Hiren N Mistri; Arvind G Jangid; Pranav S Shrivastav; Mallika Sanyal
Journal:  J Pharm Anal       Date:  2016-02-24

2.  A Liquid Chromatography - Tandem Mass Spectrometry Approach for the Identification of Mebendazole Residue in Pork, Chicken, and Horse.

Authors:  Ji Sun Lee; Soo Hee Cho; Chae Mi Lim; Moon Ik Chang; Hyun Jin Joo; Hojae Bae; Hyun Jin Park
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

3.  IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia.

Authors:  Clara Vásquez Velásquez; Graciela Russomando; Emilio E Espínola; Zunilda Sanchez; Kota Mochizuki; Yelin Roca; Jimmy Revollo; Angelica Guzman; Benjamín Quiroga; Susana Rios Morgan; Roberto Vargas Ortiz; Alberto Zambrana Ortega; Eida Espinoza; Juan Eiki Nishizawa; Mohamed Gomaa Kamel; Mihoko Kikuchi; Shusaku Mizukami; Kesara Na-Bangchang; Nguyen Tien Huy; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2019-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.